Stockscreener 앱 받기
7.155
9.91%
0.645
시간 외 거래:
7.16
0.005
+0.07%
전일 마감가:
$6.51
열려 있는:
$6.57
하루 거래량:
2.86M
Relative Volume:
2.12
시가총액:
$524.69M
수익:
$11.40B
순이익/손실:
$-95.73M
주가수익비율:
-2.9204
EPS:
-2.45
순현금흐름:
$-64.37M
1주 성능:
+3.25%
1개월 성능:
-4.34%
6개월 성능:
-14.72%
1년 성능:
+88.79%
1일 변동 폭
$6.43
$7.31
1주일 범위
$6.23
$7.31
52주 변동 폭
$3.49
$12.22
Mind Medicine Inc Stock (MNMD) Company Profile
명칭
Mind Medicine Inc
전화
212-220-6633
주소
ONE WORLD TRADE CENTER, NEW YORK
MNMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
7.155 | 524.69M | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-20 | 개시 | Chardan Capital Markets | Buy |
| 2024-10-14 | 재개 | Leerink Partners | Outperform |
| 2024-07-24 | 개시 | ROTH MKM | Buy |
| 2024-05-29 | 개시 | Robert W. Baird | Outperform |
| 2024-04-15 | 개시 | Leerink Partners | Outperform |
| 2023-12-05 | 개시 | Canaccord Genuity | Buy |
| 2022-12-09 | 재개 | ROTH Capital | Buy |
| 2022-11-16 | 개시 | RBC Capital Mkts | Outperform |
| 2022-08-26 | 개시 | Oppenheimer | Outperform |
| 2022-08-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-05-04 | 개시 | ROTH Capital | Buy |
| 2021-06-28 | 개시 | Maxim Group | Buy |
모두보기
Mind Medicine Inc 주식(MNMD)의 최신 뉴스
Why Mind Medicine Stock Is Soaring Today - MSN
Where are the Opportunities in (MNMD) - Stock Traders Daily
Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 6.4%What's Next? - MarketBeat
Barclays PLC Has $775,000 Stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat
MindMed gives more detail to investors in latest presentation - Green Market Report
Psychedelic drug developer Lykos could get lifeline from former Tesla board member - Seeking Alpha
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Mind Medicine Inc Reports Topline Data from Phase 1 Trial of MM-110 in Development for Treatment of Opioid Withdrawal - Marketscreener.com
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap UpHere's What Happened - MarketBeat
Institutional investors are Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) biggest bettors and were rewarded after last week's US$73m market cap gain - Simply Wall St
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 7.8% HigherShould You Buy? - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 3.7%Should You Sell? - MarketBeat
MindMed to Participate in the Jefferies Global Healthcare Conference - Marketscreener.com
Geode Capital Management LLC Has $9.55 Million Stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Purchased by Barclays PLC - MarketBeat
(MNMD) Investment Analysis - Stock Traders Daily
Mind Medicine's chief medical officer sells shares worth $49,357 - Investing.com India
Mind Medicine's chief medical officer sells shares worth $49,357 By Investing.com - Investing.com Australia
Mind Medicine CEO Robert Barrow sells shares worth $141,957 By Investing.com - Investing.com Nigeria
Mind Medicine's chief legal officer sells $33,576 in stock - Investing.com India
Mind Medicine CEO Robert Barrow sells shares worth $141,957 - Investing.com India
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) CEO Sells $141,957.58 in Stock - MarketBeat
Carrie Liao Sells 2,273 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Stock - MarketBeat
Mind medicine's chief accounting officer sells shares for $16,888 By Investing.com - Investing.com Canada
Mind Medicine’s chief medical officer sells shares worth $49,357 By Investing.com - Investing.com Nigeria
Mind Medicine's chief legal officer sells $33,576 in stock By Investing.com - Investing.com South Africa
Mind Medicine’s chief legal officer sells $33,576 in stock By Investing.com - Investing.com Nigeria
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 8.5%Here's Why - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap DownHere's Why - MarketBeat
MindMed Stock Skyrockets 94% Year to Date: What's Driving It? - MSN
MindMed Stock Skyrockets 94% Year To Date: What's Driving It? - Barchart
5 Biotech Breakthrough Stocks to Watch in 2025 - Yahoo Finance
Chardan Capital Initiates Coverage of Mind Medicine (MNMD) with Buy Recommendation - MSN
Mind Medicine (MindMed) (NASDAQ:MNMD) Now Covered by Chardan Capital - MarketBeat
Wellington Management Group LLP Purchases 109,152 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat
MindMed joins Nasdaq Biotechnology Index - Investing.com
MindMed to Be Added to the Nasdaq Biotechnology Index - Business Wire
Objective long/short (MNMD) Report - Stock Traders Daily
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 4.9% HigherStill a Buy? - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Receives "Outperform" Rating from Oppenheimer - MarketBeat
MindMed doses first subject in trial of tablets for generalised anxiety disorder - Yahoo Finance
Mind Medicine Mindmed Inc (MNMD-Q) QuotePress Release - The Globe and Mail
MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD) - newsbreak.com
Brokerages Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Price Target at $27.71 - MarketBeat
Mind Medicine's SWOT analysis: stock poised for growth in anxiety treatment By Investing.com - Investing.com South Africa
Mind Medicine's SWOT analysis: stock poised for growth in anxiety treatment - Investing.com India
Mind Medicine Inc (MNMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.65%
4.62%
자본화:
|
볼륨(24시간):